A type of immune cell can help predict which patients may benefit most from cancer immunotherapies, researchers from King’s College London, Guy’s and St Thomas’ Hospital Trust, and the Francis Crick Institute have found.
Dave Lennon’s CEO adventure goes from preclinical to commercial; GSK vet embarks on new Odyssey with Gary Glick
After stepping into the CEO post for the first time about two years ago, taking over the helm of “tissue therapeutics” startup Satellite Bio, Dave